Overview

This trial is active, not recruiting.

Condition addiction
Treatment mobile continuing care
Sponsor Azusa Pacific University
Collaborator National Institute on Drug Abuse (NIDA)
Start date February 2012
End date December 2014
Trial size 80 participants
Trial identifier NCT01632735, 1K01DA027754-01A1, 5K01DA027754-03

Summary

The primary purpose of this study is to test the effectiveness of a pilot mobile based continuing care program (monitoring/feedback texting) relative to standard continuing care as usual in reducing relapse and improving psychosocial functioning outcomes in a youth population (under 24) with substance abuse problems.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose supportive care
Arm
(Experimental)
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
mobile continuing care
Behavioral: Mobile Texting 12-week intervention. Delivers daily Recovering monitoring, self-management feedback, and education/social support
(No Intervention)
Continuing care as usual to 12-step facilitation (Anonymous group)

Primary Outcomes

Measure
Substance use (methamphetamine, marijuana, other)
time frame: over the 9 month study period

Secondary Outcomes

Measure
Psychosocial functioning
time frame: over the 9-month study
Recovery motivation, self management and confidence (self-efficacy)
time frame: over the 9-month study
Social Support Utilization
time frame: Over the 9-month study

Eligibility Criteria

Male or female participants from 12 years up to 24 years old.

Inclusion Criteria: 1. Youth between 12 and 24 years old 2. Youth in treatment for substance abuse 3. Youth who complete treatment (minimum 12 weeks) 4. Youth who have the cognitive capacity to understand study procedures and agree to participate Exclusion Criteria: 1. Presence of an adverse (life threatening) medical condition that could interfere with study participation. 2. Presence of psychiatric co-occurring illness or symptoms warranting safety concerns or continued treatment, including acute suicide risk; and 3. Current homelessness (unless residing in recovery home for which contact information can be provided).

Additional Information

Official title Mobile Continuing Care Approach for Youth
Principal investigator Rachel Gonzales-Castaneda, MPH, PhD
Description This study will include approximately 80 participants randomized to either 12 weeks of mobile continuing care (intervention) or standard continuing care as usual (control). Participants will be recruited from the treatment programs in Los Angeles County, including Matrix Institute on Addictions, Tarzana Treatment, Twin Town, Phoenix House, and Cri-Help. During the 12-week active program, participants will be monitored monthly via telephone data collection. Both groups will be followed for 10-months using repeated assessments (self-report and urine specimens) at baseline (month 0) and at follow-up points (months 3, 6, and 9).
Trial information was received from ClinicalTrials.gov and was last updated in July 2014.
Information provided to ClinicalTrials.gov by Azusa Pacific University.